SBI Securities’s DNA X Inc SONM Stock Holding History

SBI Securities’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$991	Buy	217 +3	+1%	+$11	﹤0.01%	2855
2026 Q2	$1.1K	Hold	214	–	–	﹤0.01%	2773
2026 Q1	$862	Hold	214	–	–	﹤0.01%	2714
2025 Q4	$674	Sell	214 -1	-0.5%	-$9	﹤0.01%	2767
2025 Q3	$2.33K	Buy	215 +173	+412%	+$2.01K	﹤0.01%	2362
2025 Q2	$932	Buy	42 +6	+17%	+$148	﹤0.01%	2710
2025 Q1	$1.4K	Hold	36	–	–	﹤0.01%	2443
2024 Q4	$2.06K	Buy	+36	New	+$2.15K	﹤0.01%	2303

Other funds holding SONM

C2C Wealth Management Scottsdale, Arizona $128M AUM 19.37% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

SBI Securities's SONM Position: Q3 2026 in Review

SBI Securities increased its DNA X Inc (SONM) stake by 1.4% in Q3 2026, buying an estimated $11 and bringing the position to 217 shares worth $991. The position accounts for ﹤0.01% of the portfolio, ranked #2855.

SBI Securities first reported a position in SONM in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.33K in Q3 2025. 4 funds tracked by Wall St. Rank hold SONM as of Q3 2026.

SBI Securities held 217 shares of DNA X Inc worth $991 as of Q3 2026.
SBI Securities bought 3 DNA X Inc shares in Q3 2026, an estimated $11.
DNA X Inc made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #2855 holding.
SBI Securities first reported a position in DNA X Inc in Q4 2024 and has held it in 8 quarters since.
SBI Securities's DNA X Inc position peaked at $2.33K in Q3 2025.
4 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.